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Abstract
In the present work we describe both the prevalence and the histopathologic features of a novel papillomavirus (referred as McPV2) that naturally
infects the rodentMastomys coucha. Viral DNA could be isolated not only from anogenital wart-like lesions but also from healthy tissues (e.g. liver,
kidney, spleen and intestine) without apparent signs of infection. Our finding of a second papillomavirus infectingM. coucha, phylogenetically very
distant from the previously known MnPV, reinforces the growing view of warm-blooded vertebrates as being hosts for a number of different
papilloma virus types that are not necessarily closely related. The histological descriptions of McPV2-associated anogenital lesions provided here,
together with earlier knowledge on MnPV-associated skin carcinogenesis, defineM. coucha as an excellent system where the link between infection
towards malignancy can be studied in molecular, histochemical and immunological terms in immunocompetent animals. The availability of such an
in vivo model also offers the unique opportunity to address defined questions about prophylactic and therapeutic strategies against different
papillomavirus infections in their natural host. To date, McPV2 is the first rodent papillomavirus found in anogenital lesions.
© 2007 Elsevier Inc. All rights reserved.Keywords: Mastomys coucha; MnPV; Skin carcinogenesis; CondylomaIntroduction
Extensive studies have established a causal relationship be-
tween high risk human papillomaviruses (HPVs) and the devel-
opment of cervical cancer (for review, see Zur Hausen, 2002).
Additionally, particular cutaneous HPVs have transforming
properties in vivo (for review, see Akgül et al., 2006) and are
involved in skin carcinogenesis of immunosuppressed and/or
genetically predisposed patients (for review, see Majewski and
Jablonska, 2006; Nindl et al., 2007). However, the pathogenic
nature of host–virus interactions ofmost papillomaviruses (PVs)
is still inadequately understood, mainly hampered by the ab-⁎ Corresponding authors. Angewandte Tumorvirologie, Abteilung Virale
Transformationsmechanismen, Deutsches Krebsforschungszentrum, Im Neuen-
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doi:10.1016/j.virol.2007.12.012sence of suitable model systems (Woodman et al., 2007). The
dependency on epithelial differentiation and their almost strict
species specificity are the main hindrances for the study of the
natural viral life cycle and events leading in some cases to ma-
lignant transformation (Middleton et al., 2003; Doorbar, 2005).
During the last years this drawback has been overcome by the
use of raft cultures which mimic the in vivo differentiation pro-
cess under tissue culture conditions (Chow and Broker, 1997).
Transgenic mice were also helpful to understand the oncogenic
potential of particular PVs, targeting viral genes to specific
tissues and monitoring their pathological outcome (Helfrich
et al., 2004; Schaper et al., 2005; Dong et al., 2005). However, the
field of in vivo models in the context of an organism, i.e. the
ordinary history of a PV infection in its natural host, is still
underrepresented. The development of such an in toto approach
would allow us to explore different aspects of carcinogenesis in a
complex system of immunocompetent animals.
Fig. 1. Examples ofMcPV2 induced lesions. (A) Anus, (C) vulva. The exophytic
condyloma-like growth is indicated by arrows. Right: Microscopic examination
of the same lesions after staining with hematoxylin–eosin (HE). (B) Anus.
(D) Vulva. Panel E: PCR analysis of DNA extracted from skin, eyelid, anus and
vulva using E6/L1 primers ofMnPV. To confirm an equal DNA input for the PCR
reaction, actin primers were used to amplify an endogenous reference gene.
187J. Nafz et al. / Virology 374 (2008) 186–197The soft furred multimammate rat Mastomys coucha, earlier
assigned to the speciesMastomys natalensis (Haag et al., 2000), is
latently infected with M. natalensis papillomavirus (MnPV)
(Müller and Gissmann, 1978; Amtmann et al., 1984). These
animals develop spontaneously benign skin lesions such as
papillomas and keratoacanthomas (Rudolph et al., 1981;
Amtmann et al., 1984). The viral DNA is present in an episomal
form not only in skin, but also in awhole variety of internal organs,
including brain and viral transcription can be detected both in
hyperproliferative tissues as well as in tumors (Nafz et al., 2007).
Excluding a maternal–foetal transmission route (Nafz et al.,
2007), it is assumed that similar to the acquisition of HPV in early
infancy (Antonsson et al., 2003), animals get infected very early in
their lifespan throughmicrolesions, wherebymale animals show a
higher incidence of skin tumor formation. The copy numbers of
MnPV in healthy skin increases over time and is strongly depen-
dent on the presence of tumors at other sites of the same animal, as
determined by hair follicle DNA analysis (Nafz et al., 2007).
Remarkably, these animals also develop condyloma-like
lesions at anogenital regions, but the biopsies surprisingly re-
vealed low incidence rates or even a complete absence of MnPV
DNA. This raised the question whether a different virus might be
etiologically involved. Taking advantage of the modified rolling
circle amplification (RCA)method (Rector et al., 2004), we have
analysed those lesions for the presence of additional PV types.
Here, we have identified and characterised a novel virus that we
propose to name M. coucha papillomavirus 2 (McPV2) and
provide information about the distribution and transcription
pattern within its natural host.
Results and discussion
Types of skin lesions in M. coucha
As reported earlier, the M. coucha colony at the DKFZ is
latently infected with theM. natalensis papillomavirus (MnPV)
which induces spontaneously papillomas and keratoacanthomas
to a frequency of 30–40% at the age of about 1 year (Amtmann
et al., 1984; Amtmann and Wayss, 1987). Systematic analyses
for the presence and distribution of MnPV in these animals
revealed that viral DNA can be detected not only in the skin, but
also in internal organs, blood, the lymphatic system and even in
brain (Nafz et al., 2007).
Notably, seeking for additional pathological changes, a
number of animals also showed condyloma-like lesions at the
anus, the penis and the vulva. Considering our colony (currently
380 animals), approximately 7–8% of them develop such
lesions at an age of around 8 months. Fig. 1 (panels A and C)
depicts two representative examples of the morphology of
anogenital lesions exhibiting an exophytic papillary keratotic
character. Panel B and D shows a microscopic overview of the
corresponding paraffin-embedded tissues after staining with
hematoxylin/eosin (HE). Here, characteristic histopathological
features of papillomavirus-induced lesions such as pronounced
epidermal hyperplasia, papilla-like structures and hyperkerato-
sis can be detected. Besides these lesions, these two animals
also had MnPV positive papilloma-like tumors on the eyelid. Inone animal, MnPV DNA could be also detected in apparently
healthy skin (Fig. 1E).
In contrast, monitoring DNA extracted from the anus or the
vulva for the presence of MnPV, none of them were found to be
positive, even after application of 30 PCR cycles. To exclude
possible structural rearrangement or deletion of the MnPV DNA
in these particular lesions, two distal sets of primer were applied,
spanning the early and late open reading frame (E6 and L1),
respectively. Screening total DNA by PCR analyses, both of
them were found to be negative for MnPV (Fig. 1E). However,
considering the fact that many species, including humans,
chimpanzees, gorillas, cows, dogs or dolphins are the host of
multiple different papillomavirus (PV) infections (Antonsson
and Hansson, 2002), we next addressed the question whether the
failure to detect MnPV could be due to the involvement of other
PVs that may infect M. coucha at these sites.
Isolation of a novel M. coucha papillomavirus
Initial screening of anogenital lesions with MnPV-specific
primers under low stringent hybridization conditions failed to
detect any related viral sequences. We therefore used the rolling
circle amplification (RCA) technique which selectively amplifies
any circular double-stranded DNA without prior knowledge of
the viral sequence (Rector et al., 2004). DNA obtained from eye
188 J. Nafz et al. / Virology 374 (2008) 186–197and anal lesions were cleaved with HindIII and XbaI, two
enzymes known to cut MnPVonce, as well as with PvuII, having
several recognition sites (Tan et al., 1994). Visualizing the bands
in an ethidium bromide stained agarose gel, both HindIII and
XbaI generated one prominent MnPVunit-length DNA fragment
of approximately 7.6 kb in size (Fig. 2, panel A, left), while RCA
treatedDNA from the anus yielded two bands (indicated bywhite
circles), whose addition resulted to a fragment of approximately
7.5 kb in length (Fig. 2, panel A, right). Hybridization of the filter
after Southern blotting with aMnPV-specific probe revealed only
positivity of the DNA extracted from the eyelid (see also Fig. 1,
panel E), whereas the RCA treated DNA from the anus wasFig. 2. Rolling circle amplification (RCA) of DNA extracted from eyelid and anal
lesions. (A) Ethidiumbromide-stained DNA gel RCA amplicons digested with
different restriction enzymes as indicated. HindIII and XbaI are single cutter for
MnPV, whereas PvuII is a multi-cutter for MnPV. The white circles highlight the
differences in the digestion pattern of the two RCA amplicons obtained after
cleavage with the respective restriction enzymes. M: HindIII digested λ phage
DNA as size marker. (B) Southernblot of the DNA gel hybridised with
radioactive MnPV-specific probe. Here, no cross-hybridization with DNA
amplified from the anal lesion could be discerned. The HindIII/XbaI linearized
MnPVDNA is indicated as unit-lengthMnPV. (C) Same as (B), after re-probing a
duplicated filter with the 32P-labeled larger HindIII fragment (see panel A).
Fig. 3. Genomic organization ofM. coucha papillomavirus 2 (McPV2). (A) Sche-
matic overview of McPV2. The location and distribution of the early (E) and late
(L) open reading frames (ORFs) are indicated. URR=upstream regulatory region.
(B) Positions of the start and stop codon of the different ORFs and the cor-
responding URR. (C) Position of potential binding sites for some important tran-
scription factors (e.g. AP-1, E2, Sp1) within the URR, known to be involved in
viral gene regulation. A stringent criterion was applied to predict transcription
factor binding sites with MATCH and confirmed by CISTER. Only those factors
were chosen with a score above a high cut-off value to minimise false negative and
positive outputs.negative (Fig. 2, panel B). The two bands obtained after HindIII
digestion were cloned and sequenced. The upper was used for re-
probing the filter, demonstrating that there was no cross-
hybridization with MnPV (Fig. 2, panel C). Final sequencing
of a cloned full-length fragment revealed a completely newTable 1
Location and size of the different proteins encoded by McPV2
ORF nt start position
in the genome
Length
(aa)
Estimated MW
(Da)
Theoretical
pI
E6 1 139 15,596.2 8.39
E7 420 109 12,079.8 4.52
E1 733 614 69,742.0 5.79
E2 2504 372 42,496.4 8.55
L2 3707 531 56,901.4 4.80
L1 5235 541 61,084.2 8.16
The estimated molecular weight (MW) in Dalton (Da) and the theoretical
isoelectric point (pI) is indicated.
189J. Nafz et al. / Virology 374 (2008) 186–197papillomavirus (accession number DQ_664501). Since it is now
known that the animals belong to the genus M. coucha (Haag
et al., 2000), the novel virus was designated as M. coucha
papillomavirus type 2 (McPV2), taking into account that MnPV
was the first PV found in this particular host.
Sequence analysis and genome organization
The complete genome of McPV2 (see Fig. 3A, for schematic
overview) consists of 7522 bp and shows the basic structure
common to all PVes. It encodes for six major open readingFig. 4. Phylogenetic analysis of McPV2. (A) Consensus eurogram for the concatenated E
infecting rodents are labelled in boxes. Exclusively topology and not distances are de
classification based on the E1E2 proteins is provided on the right. Black circles, black
values above 80%, between 60% and 80%, and between 50% and 60%, respectively. PV
hamster oral PV (HaOPV) and belongs confidently to themammalianPVsupergenusC, f
infecting human, dog, hamster andM. coucha. (B) Bootstrap support for the different nod
stretches without phylogenetic structure were removed with GBLOCKS, and the resul
Bayesian inference with the BEAST software and for maximum likelihood with the R
posterior probabilities or after 500 cycles bootstrap (maximum likelihood). Distance va
and support for the Fitch-Margoliash algorithm is given under “f/m”. Values are giv
(C) Evolutionary distances expressed as substitutions per site, measured for the E6, E7, E
and HaOPV (the closest relative), Mammalian PV C (the cladeMcPV2 belongs to),Mam
PVs, as defined according to the E1E2-based classification. The evolutionary distancesframes (ORFs) on one coding strand, with four early (E) and two
late (L) proteins. Fig. 3B summarizes the start and the end of the
different ORFs. The exact location, length (in amino acids), the
estimated molecular weight and the theoretical isoelectric point
of the encoded proteins are presented in Table 1. Similar to other
skin PVs (for review, see Pfister, 2003), there is no hinge region
between E2 and L2 in theMcPV2 genome and therefore no ORF
encoding for E5-like proteins can be detected (Bravo and
Alonso, 2004). McPV2 shares this feature also with closely
related PVs that infect skin in rodents (e.g. HaOPV) or MmPV
in primates (e.g. HPV4, HPV5, HPV92 or HPV101), carnivores1E2L1 sequences from a phylogenetically representative selection of PVs. Viruses
picted. PV classification based on the L1 gene is provided in brackets, while PV
circumferences and dashed black circumferences label nodes with average support
s infecting rodents are shown in black boxes. McPV2 clusters confidently with the
ollowing the E1E2-based classification. This supergenus encompasses therefore PV
eswithin theMammalian PV supergenus C, as labelled in the eurogram. Alignment
t processed with parsimony and distance methods with the PHYLIP software, for
AxML software. Results are given in percentage after 1000 cycles bootstrap, as
lues for Neighbor-Joining and UPGMA are combined and given under “distances”
en for both amino acid-based and nucleotide-based (in parentheses) inferences.
1, E2, L2 and L1 proteins. Distances were measured between theMcPV2 sequence
malian PVB (the closest clade), the rest ofMammalian PV supergenera and Avian
increment in the following order: L1bE1bL2∼E2bE6∼E7.
Fig. 4 (continued ).
190 J. Nafz et al. / Virology 374 (2008) 186–197(e.g. COPV2) or ruminants (e.g. BPV3). The E1^E4 proteins,
are usually expressed after splicing event that links the first five
amino acids of E1 to the E4 ORF, nested within E2 on a different
reading frame. We were not able to identify any putative E4
ORF, as the two alternative reading frames in E2 were inter-
rupted by several stop codons. Thus, although remnants of the
proline-rich stretches that characterise E4 could be identified, we
cannot confirm the existence of a true E4ORF inMcPV2. This is
not a trivial point, because E1^E4 is the most expressed protein
in many HPV infections (Doorbar, 2005; Longworth and
Laimins, 2004). Further work characterising the McPV2
transcriptome and a comparison with those in closely related
viruses will hopefully provide an explanation to this question.
The McPV2 E6 protein contains two conserved zinc-binding
domains, CX2C–X29–CX2C, separated by 36 amino acids,
whereas the E7 contains one such domain. A putative retino-
blastoma tumor suppressor-binding domain (DLLCHENLDDPE)
is found in the E7 protein. Whether E6 and E7 definitively
represent the only viral oncoproteins of McPV, remains to be
investigated in further studies. Notably, at least in the case of
MnPV, a supportive transforming effect could be confirmed in
transgenic mice encoding the E6 oncoprotein under the control of
the cytokeratin 14 promoter. Targeting viral gene expression to
the basal layer of the skin, we could demonstrate that under
conditions where the classical two-stage skin carcinogenesisprotocol was applied (Fürstenberger andKopp-Schneider, 1995),
squamous cell carcinomas developed in nearly 100% of the E6
expressing transgenic mice in comparison to only 10% in the
non-transgenic littermates (Helfrich et al., 2004). In contrast,
corresponding MnPV E7 transgenics were not viable, probably
due to the proapoptotic properties of the E7 protein (Nauenburg
et al., 2001).
E1 encodes for the largest McPV2 protein of 614 amino
acids (Table 1). The ATP-binding site of the ATP-dependent
helicase (GPPDTGKS) is conserved in the carboxy-terminal
part of E1. The E2 protein can be also divided in an N-terminal
trans-activation and a C-terminal DNA-binding/dimerization
domain separated by a variable hinge region (Hegde and
Androphy, 1998). Both the major (L1) and minor (L2) capsid
proteins show nuclear localization signals at their carboxyter-
minus, which are characterised by KR rich sequences. A poly-
adenylation consensus sequence (AATAAA) of the early viral
mRNA transcript is present within the beginning of the L2 ORF
(nt 3806 to 3811).
The upstream regulatory region (URR), located between the
stop codon of L1 and the first ATG of E6, contains a second
polyadenylation site (AATAAA; nt 7017 to 7022) in the 5′ end,
probably involved in processing of the late mRNA transcripts.
A TATA box can be detected at the 3′ end (nt 7479 to 7482) of
the URR, possibly involved in early transcription start. Several
191J. Nafz et al. / Virology 374 (2008) 186–197putative transcription factor binding sites (TFBS), which are
listed in Fig. 3C, are present. Here, the viral E2 protein plays
decisive roles in the viral cycle, since it regulates both viral
DNA replication and transcription (for review, see Hegde,
2002). E2 binds as dimers to the cognate palindromic consensus
sequence 5′-ACC(N)6GGT-3′ (Androphy et al., 1987), where 3
potential sites can be identified at pos. 7229–7244, 7285–7299
and 7462–7575, respectively. Comparing the URR of its closest
relative, the hamster oral PV (HaOPV) (Iwasaki et al., 1997),
the distribution pattern of TFBS is highly conserved (data not
shown). Furthermore, both regulatory sequences contain a
similar palindromic sequence (McPV2 position 7132–7143 and
7151–7163) whose function is still to be defined.
Referring to cellular transcription factors, known to maintain
PV gene expression (for review see, Hoppe-Seyler and Butz,
1994; Bernard and Apt, 1994), the McPV2 URR also harbours
two potential binding sites for the activator protein-1 (AP-1)
(pos. 7092–7102 and 7343–7350). AP-1 has been shown to be
indispensable for almost all PV (Sailaja et al., 1999), since
deletion or mutation of the corresponding recognition sites
completely abrogates transcriptional activity (Butz and Hoppe-
Seyler, 1994). In addition, there is also a binding site for the
ubiquitous transcription factor Sp1 (pos. 7496–7503) which
controls, in conjunction with Sp3, papillomavirus gene
expression during differentiation (Apt et al., 1996).
McPV2 phylogeny
Hitherto only five complete genome sequences from PVes
that infect rodents are deposited in the databases, corresponding
to hamster, harvest mouse, porcupine and M. natalensis (now
termed coucha) (Fig. 4A, black boxes). The finding of a second
PV, naturally infecting M. coucha, but phylogenetically distant
fromMnPV suggests that rodents are possibly the host of several
types of different PV genera, as in the case of primates, carnivora
and cetartiodactyls. For the phylogenetic reconstruction, only
the unambiguously codon-aligned sequences of the concate-
nated E1, E2 and L1 ORFs were used (Fig. 4B). The consensus
eurogram for a phylogenetically representative selection of PV
sequences is shown (Fig. 4A). Two different PV classification
systems based either on the L1 gene (in brackets) (de Villiers
et al., 2004) or on the E1E2 proteins (on the right) (Bravo and
Alonso, 2007) are provided as a reference. McPV2 clusters
confidently with the hamster oral PV HaOPV and both belong
with good support to the mammalian PV supergenus C, which
encompasses PVes infecting primates, carnivora, artiodactyla
and rodentia. The topology of the tree presented here obviously
contradicts the extended assumption of PVes having co-evolved
parsimoniously with the hosts (Gottschling et al., 2007a). If
plain co-evolution had occurred between rodents and PVes that
infect rodents, all viruses that infect similar hosts should branch
together in the tree, but this is not the case. Thus, MnPV1 is not
the closest relative of McPV2, but for both of them,M. coucha is
the natural host. Besides, the closest relative of porcupine PV
EdPV is not a rodent PV but human PV41. Other mechanisms
such as recombination (Bravo and Alonso, 2004; Narechania
et al., 2005; Varsani et al., 2006), changes in the micro- or macro-ecological conditions (Garcia-Vallve et al., 2006; Narechania
et al., 2005) or interspecies transmission (Gottschling et al.,
2007a,b) might have also been involved in PV evolution
(Gottschling et al., 2007a,b).
We have also analysed the evolutionary distances individu-
ally for each ORF, as measured from the McPV2 tip to the
different nodes defined with confidence (Fig. 4C). The number
of substitutions per site increases in the order L1bE1b
L2∼E2bE6∼E7, which shows that L1 protein is relatively
conserved whereas E6 and E7 seem to undergo a rapid
evolutionary process. These data support the notion that early
proteins have evolved faster than late proteins along the history
of PVes, as has already been described for different ORFs and
for different PVs (Bravo and Alonso, 2004; Garcia-Vallve et al.,
2006; Bravo and Alonso, 2007). The number of substitutions
accepted is therefore higher in proteins expressed in the lower
layers of the epidermis in the early stage of the infection, and
that are potentially exposed to the immune system. On the
contrary, the capsid proteins are expressed in the upper layers of
the epidermis in the late stages of the infection and might be less
exposed to immune surveillance. It is therefore tempting to
speculate that at least one of the evolutionary forces that drive
the faster evolutionary rates of the oncogenes E6 and E7 is a sort
of red Queen race against the immune system.
Presence and distribution of McPV2 in M. coucha
As shown in our previous study, MnPV can also persist in
inner organs (Nafz et al., 2007). To monitor whether the novel
virus has a similar distribution pattern in its natural host, we
autopsied animals and screened for the presence of McPV2
DNA. In order to avoid false positive PCR results, extreme care
was taken to exclude cross-contamination. DNA extracted from
different specimens were analysed by PCR primers encompass-
ing the E6 ORF McPV2 and compared with the presence of
MnPV. Notably, comparing the occurrence of viral DNA (in
total, a cohort of 20 animals was investigated), an obvious
inverse correlation of MnPV/McPV2 prevalence for internal
organs could be observed, with the exception of the skin and
benign tumors, where occasionally both viruses can be detected.
Fig. 5A illustrates a representative example of an animal that was
positive for both viruses. Here, McPV2 was dominant in organs
such as liver, kidney, spleen and intestine, whereas MnPV could
be only found in the forestomach and in skin (Fig. 5A). This
indicates that McPV2 has a similar tropism as previously
described for MnPV (Nafz et al., 2007), but a co-existence of
both viruses in internal organs seems to be mutually exclusive.
AlthoughMnPV/McPV2 positivity of organs was not accom-
panied by obvious pathological changes, M. coucha may serve
as a model to study the question of a broader causal relationship
of MnPV/McPV2 in their natural immunocompetent host. It
remains to be seen in further experiments whether the presence
of MnPV/McPV2 in different organs may also help to under-
stand the involvement of HPV sequences in various other types
of human cancer, e.g. in colon (Buyru et al., 2006), lung (Ciotti
et al., 2006), esophageal and gastric cancers (Kamangar et al.,
2006) as well as in urothelial tumors (Kuwahara et al., 1998).
Fig. 5. Prevalence of MnPV and McPV2 DNA within the skin and different
lesions. (A) Ethidium bromide-stained gel of PCR analyses to examine the skin
and different organs for the presence MnPVand McPV2 DNA. Viral-specific E6
primers and mouse-specific actin primers were used for PCR. The upper band of
the actin PCR represents its pseudogene, which was confirmed by DNA
sequencing. (B) Southernblot analysis: total genomic DNA obtained from
different lesions (skin papilloma, foreskin, tongue and anus) was digested with
HpaII (1), MspI (2) and HhaI (3) to monitor the methylation status of the viral
DNA. The upper filters were hybridized with full-length labelled MnPV, the
lower two filters with a labelled McPV2 probe.
192 J. Nafz et al. / Virology 374 (2008) 186–197The inverse relationship between the prevalence of both
viruses can be further substantiated by Southernblot analyses
(Fig. 5B). In addition, since it is known that PVes were also
targeted by de novo methylation that modulates viral transcrip-
tion (Rösl et al., 1993; Badal et al., 2003), we monitored the
epigenetic status of McPV2/MnPV in various lesions (Fig. 5B).
DNA extracted from skin, foreskin and tongue was digested
with restriction enzymes sensitive or insensitive to CpG
methylation in their recognition site. MspI cuts independently
of the methylation status, whereas its isoschizomer HpaII and a
further enzyme (HhaI) cannot cleave when the DNA is
methylated. As depicted in Fig. 5B, consecutive hybridization
of the same filter with MnPV and McPV2 probes revealed the
absence of off-size bands, indicating that the majority of the
viral DNA persists in an extrachromosomal state. Moreover,
there were no differences between HpaII (lane 1) and MspI
(lane 2). Also after digestion with HhaI (lane 3), lacking a
corresponding isoschizomer, an expected cleavage pattern was
revealed. This excludes at least a general de novo methylation
of both episomal MnPV/McPV2 DNAs, contrasting the
situation when PVes were integrated and targeted by the host
cell epigenetic machinery (Kim et al., 2003).Immunostaining and in situ hybridization
To gain insight in the histological features and the distribution
of McPV2 and MnPV genomes in anogenital lesions, paraffin
embedded normal and pathological vulva tissue was stained with
hematoxylin and eosin (HE), while consecutive sections were
used for in situ hybridization (ISH) with MnPV and McPV2
DNA as specific probes. Fig. 6 shows a representative overview
of normal HE stain of the vulva (panel A), being negative for both
viral DNAs (panel B and C). Conversely, examining condyloma-
like dysplastic tissue, HE staining reveals quite obvious
pathological changes, considered to be hallmarks for papilloma-
virus infection (Lee et al., 1997): epithelial hyperplasia with
irregular enlarged, wrinkled hyperchromatic nuclei and koilocy-
tic perinuclear halos (Fig. 6D, see also panel G, indicated by
arrows after higher magnification). Notably, using the biotinyl-
tyramide-based ISH technique (Evans et al., 2002), there was no
ubiquitous spreading of virus-positive cells within the superficial
and intermediate layers (e.g. stratum spinosum and the stratum
granulosum), opposite to what was recently demonstrated for
MnPV in skin lesions (Nafz et al., 2007). Instead, only few
dysplastic cells (approximately 10%) show strong hybridization
signals, indicating that abundant McPV2 replication was taking
place in isolated individual cells (Fig. 6, panel E and H). The
hybridization pattern was mainly dispersed and not punctuated,
which is consistent with previous Southern blot analyses (Fig. 5)
showing that the majority of the McPV2 DNA persists in an
episomal state (Evans et al., 2002). According to the permissive
cycle of papillomaviruses (Doorbar, 2005), no or very weak
staining could be discerned in basal cells, since non-differentiated
layers regularly harbour low copy numbers of viral DNA. A
disproportionate distribution of the viral genomes, varying in
their copy number, seems to account for the absence of positive
signals in more differentiated regions (Fig. 6, panel E), which are
apparently below the detection level achieved by ISH (McNicol
and Farquharson, 1997). Indeed, preliminary data suggest that
the viral load of McPV2 was consistently lower than in the
MnPV-induced lesions. Carrying out the same ISH with parallel
tissue samples using MnPV-specific labelled DNA, no signals
were obtained (Fig. 6, panel F and I).
Transcriptional analysis
Since under permissive conditions, a target cell may harbour
several thousand viral genomes (Doorbar, 2005), analysis of
transcriptional activity was done after repeatedDNaseI treatments
to eliminate contaminating viral DNA. As depicted in Fig. 7, both
viruses were transcriptionally active in skin, the corresponding
tumors as well as in anogenital lesions, where in this particular
specimens co-infection of MnPV and McPV2 occurred. For
analyzing viral transcription, primers covering the E6 and L1
ORF of both types were applied for RT-PCR. Actin PCR was
performed as a quality control for the DNAse I treated RNA.
Taking the intensity of the amplified fragment into account,
McPV2 mRNA was less abundantly expressed when the same
number of RT-PCR cycles was applied. As already anticipated by
ISH (Fig. 6), this was consistent with the notion that MnPV is
Fig. 7. RT-PCRanalysis of various tissues. For RNAextraction, tissuewas selected
which was positive for MnPV/McPV2 DNA as depicted (DNA PCR with L1
primers). cDNAwas analysed by PCRwith two different primer pairs representing
the early and late ORFs (E6 and L1) of both viruses. β-Actin primers were used to
control the integrity of the cellular RNA after repeated DNase treatments.
Fig. 6. Histology and in situ hybridization (ISH) of normal versus dysplastic sections of the vulva. Upper panels: Hematoxylin/Eosin (HE) staining. (A) Normal tissue.
(D and G) Dysplastic vulva tissue. The black arrows mark koilocytic atypia within the disorganized morphology of the superficial layer. (B, E, H) Consecutive sections
of normal and dysplastic vulva tissue after in situ hybridization with McPV2. (C, F, I) Absence of MnPV ISH signals in normal and dysplastic tissue. The dermis (D),
the epidermis (E) as well as the scale bars are indicated. The boxed areas in panels D, E and F show which parts are enlarged in panels G, H and I, respectively.
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Animal #2 was only expressing the E6 ORF ofMcPV2, while the
corresponding transcript spanning the late region (L1)was absent.
Whether this reflects general differences in the early-late switch
between the viruses or whether these cells are more prone to
undergo malignant transformation remains to be elucidated.
Materials and methods
Animals
M. coucha from the breeding colony of the Deutsches
Krebsforschungszentrum were kept under conventional condi-
tions at 21–24 °C and 55% relative humidity and 12–16 air
changes/h. The animals were provided with a standardised
mouse diet and allowed to drink water ad libitum.
Tissue dissection and DNA extraction
To exclude cross contamination from skin to internal organs,
scalpels, scissors and forceps were changed after every
resection. For DNA extraction, tissue was lysed overnight at
55 °C in DNA lysis buffer (1% SDS, 1 mM EDTA, 100 μg/ml
proteinase K, 20 mM Tris/HCl, pH 8) and extracted as described
(Sambrook et al., 1989).
Rolling circle amplification (RCA)
Biopsy material was obtained from papillomas or wart-like
lesions of different sites fromM. coucha. To specifically amplifycircular double-stranded DNA, multiply-primed RCA using a
TempliPhi 100 amplification kit (Amersham Biosciences,
Freiburg, Germany) following an optimized protocol (Rector
194 J. Nafz et al. / Virology 374 (2008) 186–197et al., 2004) was carried out. Briefly, approx. 500 ng of the
extracted DNAwas denatured in TempliPhi sample buffer (3 min
at 95 °C), containing exonuclease-protected random hexamers
and then cooled on ice. TempliPhi reaction buffer, containing
salts and deoxynucleotides (dNTPs) plus additional 450 μM of
dNTPS, and the TempliPhi enzyme mix, containing the ϕ29
DNA polymerase were added to the cooled DNA. Reaction was
carried out at 30 °C for 16–18 h in a Thermo-Cycler (Perkin-
Elmer). RCA results in exponential, isothermal amplification of
the circular DNA and generates linear, double-stranded, high-
molecular-weight, tandem-repeated copies of the template DNA
(Dean et al., 2001). The reaction was stopped by heating for
10 min at 65 °C and the samples were then kept at 4 °C.
Southern blotting
Southern blotting was performed by standard methods
(Sambrook et al., 1989). Briefly, 2.5–5 μg tissue DNA was
digested over night (all enzymes indicated were purchased from
NEB, Frankfurt, Germany). In the case of RCA, 2 μl of each
RCA product was digested with 10 U of different restriction
enzymes for 3 h at 37 °C. The DNA was separated in a 1%
agarose gel by electrophoresis, blotted on gene screen plus
membrane (Perkin Elmer, Rodgau-Jügesheim, Germany) and
hybridised with either a MnPV (Amtmann et al., 1984) or
McPV2 specific probe. 75–100 ng DNAwere labelled with 32P-
dCTP using the HexaLabelling kit (MBI Fermentas, St. Leon,
Germany). Hybridization was carried out at 37 °C overnight,
followed by three washing steps at 68 °C with 2× SSC an 0.1%
SDS. The filters were exposed to X-ray films for 8 h to 14 days.
Cloning
Digestion of the RCA amplified DNA of anogenital lesions
with HindIII generated two bands of approx. 3200 and 4300 bp
in size, which were gel-purified (QiaexII gel purification kit,
Qiagen, Hilden, Germany) and cloned in pBluescript KS vector.
After ligation, chemocompetent “One Shot Top10” bacterial
cells (Invitrogen, Karlsruhe, Germany) were transformed and
plated on Ampicillin/X-Gal-containing agar-plates. White
colonies containing the inserts were selected and sequenced.
The two fragments encompassed the whole genome of the novel
virus. To obtain the complete genome, the RCA DNA was
digested with the single cut enzyme SalI, producing one single
band which was cloned and re-sequenced at the Sequencing
facility of the DKFZ Heidelberg, Germany.
Phylogenetic analysis
A representative selection of sequences from human PVs
was chosen, adequately covering all the main subtaxa, as
follows: HPV2 [NC_001352], HPV16 [NC_001526], HPV6
[NC_000904], HPV54 [NC_001676]; HPV5 [NC_001531],
HPV9 [NC_001596], HPV92 [NC_004500]; HPV4
[NC_001457], HPV48 [NC_001690], HPV60 [NC_001693],
HPV101 [NC_008189] and HPV103 [NC_008188]; HPV1
[NC_001356] and HPV 63 [NC_001458]; HPV41[NC_001354]. Non-human PV complete sequences were in-
cluded, aiming to cover the widest possible range of host
diversity, as follows: PV infecting Primates, Pan troglodytes PV
[NC_001838] (CPV), Pan paniscus PV [NC_006163] (PCPV)
andMacacca mulatta PV [NC_001678] (RHPV1); PV infecting
Rodentia, M. natalensis PV [NC_001605] (MnPV), Erethizon
dorsatum PV (EdPV) [NC_006951] and hamster oral PV
(HaOPV) [E15111]; PV infecting Cetartiodactyla, Phocoena
spinipinnis PV (PsPV) [NC_003348], Tursiops truncatus PV2
(TtPV2) [NC_008184], Bos taurus PV1 (BPV1) [NC_001522]
BPV2 [M20219], BPV3 [AJ620207], BPV4 [X05817], BPV5
[NC_004195], and BPV6 [NC_004711], Ovis aries PV1
(OPV1) [NC_001789] and OPV2, Rangifer tarandus PV (RPV)
[NC_004196], Alces alces alces PV (EEPV) [NC_001524] and
Odocoileus virginianus PV (DPV) [NC_001523]; PV infecting
Perissodactyla, Equus caballus PV EcPV [NC_004194]; PV
infecting Sirenia, Trichechus manatus latirostris PV (TmPV)
[NC_006563]; PV infecting Carnivora, Felis catus PV (FdPV)
[AF377865] and Canis familiaris, canine oral PV (COPV)
[NC_001619] and canine PV2 (CaPV2) [NC_006564]; PV
infecting Lagomorpha, Oryctolagus cuniculus PV (ROPV)
[NC_002232], ROPVb [AJ243287] and Sylvilagus floridanus
PV (CRPV) [NC_001541]; PV infecting Aves, Passeriformes,
Fringilla coelebs PV (FcPV) [NC_004068]; PV infecting Aves,
Psittaciformes, Psittacus erithacus PV (PePV) [NC_003973].
Sequence alignment and phylogenetic analysis
All algorithms were run in the HUSAR environment of the
bioinformatics facility of the Deutsches Krebsforschungszen-
trum. The E1, E2 and L1 ORF were identified (Gottschling
et al., 2007a,b), concatenated and aligned at the amino acid
level using T-COFFEE, which combines information for both
global and local homologies (Notredame et al., 2000). Con-
served positions in the original alignment were defined with the
GBLOCKS software using non-restringent conditions (freely
distributed by Dr. Castresana at http://molevol.ibmb.csic.es)
(Castresana, 2000). The refined alignments at the protein level
were used for generating codon-alignments at the DNA level,
with the PALNAL server (freely distributed by Dr. Suyama at
http://coot.embl.de/pal2nal//index.cgi) (Suyama et al., 2006).
Both refined alignments, amino acid and codons, were
processed for phylogenetic analysis using parsimony (DNA-
PARS or PROTPARS) and distances (DNADIST or PROT-
DIST) with the PHYLIP software package (freely distributed by
Dr. Felsenstein at http://evolution.genetics.washington.edu/
phylip.html) (Felsenstein, 1993). The distance matrices were
analysed with FITCH using the Fitch-Margoliash criterion and
with NEIGHBOR, under both the Neighbor-Joining (NJ) and
Unweighted Pair Group Method with Arithmetic Mean
(UPGMA) methods of clustering. The statistical support was
assessed by 1000 cycles bootstrapping with SEQBOOT and a
consensus tree was computed for each algorithm with CON-
SENSE. Alignments were also processed for Bayesian Phyloge-
netic inferencewithBEAST (freely distributed byDr. Drummond
and Dr. Raumbaut, see http://beast.bio.ed.ac.uk), using a relaxed
molecular clock (Drummond et al., 2006): at the codon-aligned
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partitioning the input into three categories, corresponding to the
three codon positions, and generating two runs of 10,000,000
cycles each; at the amino acid level the WAG model was used
(Whelan and Goldman, 2001), with four discrete gamma
categories, and generating two runs of 1,000,000 cycles each.
Maximum Likelihood Analysis was performed with RAxML
(freely distributed by Dr. Stamatakis at http://icwww.epfl.ch/
~stamatak/index.htm) (Stamatakis et al., 2005): at the codon-
aligned level the general time-reversible model with the Γmodel
of rate heterogeneity was used; at the amino acid level a rtREV
substitution model with empirical base frequencies was used
(Gottschling et al., 2007a); in both cases a 500 non-parametric
bootstrap was used.
Prediction of transcription factor binding sites
Transcription factor binding sites (TFBS) in the genome
region between the L1 and the E6 genes of the closely related
PVs McPV2 and HaOPV were predicted with MATCH,
designed for searching potential binding sites for TFBS
nucleotide sequences, using a library of mononucleotide weight
matrices from TRANSFAC 9.3 (Wingender et al., 2000). A
positive match must have a score higher than or equal to the core
similarity cut-off. We have chosen a high cut-off value, designed
to minimise both the number of false positives and false negative
in the MATCH output. Additionally, we have confirmed the
presence of the predicted TFBS in both URR using Cister, an
algorithm that uses a technique of posterior decoding based on a
hidden Markov model (Frith et al., 2001). Only elements with a
posterior probability higher than 0.8 were considered positive in
the Cister algorithm. We have chosen an extremely stringent
criterion for assessing the presence of TFBS, and only matches
appearing in both algorithms were considered true positives.
RNA extraction and Reverse Transcription
Snap frozen tissue was ground with a chilled mortor and
pestille, and the tissue powder extracted with Trizol Reagent
(Invitrogen, Karlsruhe, Germany) (100 mg tissue/ml Trizol),
following the instructions of the manual. RNA was DNase
digested with 2–4 μl Turbo DNase (Ambion, Cambridgeshire,
UK) prior to reverse transcription and 0.2 μg checked for
contaminating viral DNA by the use of virus specific primers
(MnPV and McPV L1). Approx. 2 μg of DNase digested RNA
was incubated with 3.5 μM Oligo22 dT or 200 ng random
primers for 10 min at 42 °C. 0.5 mM dNTPS, single strand
buffer, 2.5 mM DTT were added and left for 10 min at 25 °C.
After addition of 200 U Superscript II Reverse Transcriptase
(Invitrogen), the reaction was incubated at 42 °C for 50 min
followed by a final heating to 70 °C for 15 min.
PCR and RT-PCR
100–250 ng genomic DNA or 100 ng cDNA were used for
amplification by PCR in a mix containing 1.5 mM MgCl2,
200 μM dNTPs, 0.3 μM of each primer, 1× PCR buffer and 1Unit recombinant Taq polymerase (Invitrogen, Karlsruhe).
PCRs were run in Thermo Cycler MT200 (Biorad, München,
Germany) for 25 (DNA) and 28 cycles (cDNA), respectively.
The program for all amplifications was: 94 °C 4 min; 25 or 28
cycles of 30 s at 94 °C, 45 s at 58 °C and 30–60 s extension at
72 °C; final extension 10 min 72 °C. Primer sequences for
MnPV E6 forward (f): 5′-act cct ttg tgg agc ggc tg-3′, MnPV E6
reverse (r): 5′-caa att ctg cac cgt gcc ctc-3′ (product length:
378 bp); MnPV L1 f: 5′-tct aca ccc gtc att gtc ca-3′, MnPV L1 r:
5′-gcc acg agc tat ctc cac tc-3′(product length: 379 bp); McPV
E6 f: 5′-gcg ctt ttt gtg att ctc ct-3′, McPV E6 r: 5′-tgc cag tca tag
cct caa ca-3′(product length: 192 bp); McPV L1 f: 5′-tcc caa agt
ttc tgg caa tc-3′, McPV L1 r: 5′-caa aca gct cat tgc tcc aa-3′
(product length: 817 bp), actin f: 5′-acc cac act gtg ccc atc tac
ga-3′, actin r: 5′-ctt gct gat cca cat ctg ctg ga-3′.
Histology
Tissue samples were fixed in formalin and subsequently
embedded in paraffin. 2–5 μm thick sections were taken from
the paraffin blocks, placed on coated slides and fixed overnight
at 56 °C. The first cut of each specimen was stained with
hematoxylin and eosin in order to illustrate histopathological
changes, consecutive sections were used for in situ hybridiza-
tion (ISH) to analyze the presence of viral DNA.
In situ hybridization
Full-length MnPV and McPV2 genomes were cloned in
pUC19 plasmids and biotin-labelled by nick-translation (Roche,
Mannheim,Germany). 5-μmsections of paraffin-embedded tissue
were fixed at 56 °C on 3-aminopropyltriethoxysilane (APES)
coated slides overnight and deparaffinized by incubating twice in
xylene followed by rehydration in a graded ethanol series and
water. Specimens were boiled in sodium citrate buffer for 10 min
in a microwave oven and digested with pepsin (8 μg/ml 0.1 N
HCl) for 30–40 min at 37 °C. To extinguish residual peroxidase
activity, the slides were incubated in 3%H2O2 solution for 10min
and afterwards treated with 4% paraformaldehyde for 30 min. For
hybridization, the appropriate probe was added in a concentration
of 500 ng/ml in hybridization buffer (50% formamide, 2× SSC,
1 mg/ml sonificated salmon sperm DNA, 0.05 M NaH2PO4/
Na2HPO4, 1 mM EDTA) and the slides were heated at 98 °C for
8min followed by incubation at 42 °C in amoist chamber for 16 h.
The slides were then stringently washed in 2–0.1× SSC/0.05%
Tween20 from 37 °C to 55 °C. Following the instruction of the
TSA amplification kit (Perkin Elmer), slideswere incubatedwith a
streptavidin–horseradish peroxidase conjugate (dilution 1:500)
and the signal was amplified with biotinyl-tyramide (dilution
1:50). Viral DNA was then visualised by a chromogen reaction
using 3-amino-9-ethylcarbazole (AEC; DakoCytomation) and the
tissue was counterstained with hematoxylin.
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